Synovus Financial’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$926K Sell
7,287
-2,446
-25% -$291K 0.01% 537
2025
Q2
$1.19M Buy
9,733
+349
+4% +$39.9K 0.01% 464
2025
Q1
$950K Buy
9,384
+869
+10% +$84.8K 0.01% 496
2024
Q4
$786K Sell
8,515
-7,542
-47% -$740K 0.01% 530
2024
Q3
$1.55M Buy
16,057
+7,733
+93% +$695K 0.02% 412
2024
Q2
$714K Buy
8,324
+1,835
+28% +$154K 0.01% 533
2024
Q1
$536K Buy
6,489
+7
+0.1% +$513 0.01% 615
2023
Q4
$432K Buy
6,482
+23
+0.4% +$1.49K 0.01% 641
2023
Q3
$434K Buy
6,459
+482
+8% +$33.2K 0.01% 649
2023
Q2
$405K Sell
5,977
-366
-6% -$22.9K ﹤0.01% 658
2023
Q1
$343K Sell
6,343
-1,533
-19% -$89.2K ﹤0.01% 693
2022
Q4
$471K Sell
7,876
-1,689
-18% -$91.9K 0.01% 624
2022
Q3
$429K Sell
9,565
-2,187
-19% -$109K 0.01% 614
2022
Q2
$524K Sell
11,752
-3
-0% -$154 0.01% 576
2022
Q1
$658K Sell
11,755
-836
-7% -$43.6K 0.01% 542
2021
Q4
$662K Sell
12,591
-117
-0.9% -$6.04K 0.01% 554
2021
Q3
$765K Buy
12,708
+192
+2% +$12.1K 0.01% 498
2021
Q2
$777K Buy
12,516
+132
+1% +$8.8K 0.01% 498
2021
Q1
$805K Buy
12,384
+58
+0.5% +$3.78K 0.01% 445
2020
Q4
$811K Buy
12,326
+265
+2% +$15.6K 0.01% 418
2020
Q3
$624K Buy
12,061
+366
+3% +$18.8K 0.01% 437
2020
Q2
$576K Buy
11,695
+537
+5% +$29K 0.01% 430
2020
Q1
$570K Buy
11,158
+825
+8% +$47.6K 0.01% 487
2019
Q4
$575K Sell
10,333
-1,346
-12% -$73K 0.01% 436
2019
Q3
$595K Buy
11,679
+10,002
+596% +$502K 0.01% 420
2019
Q2
$85K Buy
1,677
+4
+0.2% +$194 ﹤0.01% 733
2019
Q1
$77K Sell
1,673
-121
-7% -$6.13K ﹤0.01% 737
2018
Q4
$89K Sell
1,794
-193
-10% -$11K ﹤0.01% 696
2018
Q3
$123K Buy
1,987
+822
+71% +$50K ﹤0.01% 677
2018
Q2
$64K Hold
1,165
﹤0.01% 747
2018
Q1
$54K Buy
+1,165
New +$49.9K ﹤0.01% 761
2017
Q2
Sell
-629
Closed -$21K 882
2017
Q1
$21K Hold
629
﹤0.01% 859
2016
Q4
$21K Buy
+629
New +$20.4K ﹤0.01% 832

Other funds holding EHC